Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan...Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan. Voice +81-75-751-3465; fax: +81-75-751-3574; ash@kuhp.kyoto.u.ac.jp.
to integrin plaque occlusion mitogen-activated protein artery atherosclerosis inflammation coronary p38-MAPK chemotaxis cytokines medicine cardiovascular kinase p38 cardiology inflammatory by avivagabriel on Jul 27, 2007, 10:56 PMAngiographic pattern of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation different to that after bare metal stent (BMS), but their sub...Angiographic pattern of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation different to that after bare metal stent (BMS), but their subsequent TLR rate was similar to both types of DES.
to occlusion stents medicine coronary disease restenosis drug-eluting DES interventional ISR angiography cardiology angiogram stent BMS cardiovascular artery bare-metal by avivagabriel on Jul 27, 2007, 6:46 PM- to proximal disease products LAD guidewires descending coronary artery plaque anterior devices left total occlusion chronic difficult calcification catheters by avivagabriel on Jul 16, 2007, 3:41 PM
results suggest that dietary management of insulin resistance and obesity can focus more on restricting calories and less on restricting dietary fat.
to drugs cardiologists disease vessel tests syndrome artery interventional cytokines therapies vasculature coronary inflammation PCI research vascular diagnosis lipoprotein(a) surgery studies risk guidelines prevention labs CABG endothelial stents risks anti-inflammatory medicine assessments cardiac antiinflammatory procedures Tx Dx plaque atherosclerosis radiography Rx function trials cardiovascular imaging cardiology occlusion bypass by avivagabriel on Jul 15, 2007, 9:49 PMWomen and Heart Disease The Role of Diabetes and Hyperglycemia Elizabeth Barrett-Connor, MD; Elsa-Grace V. Giardina, MD; Anselm K. Gitt, MD; Uwe Gudat, M...Women and Heart Disease The Role of Diabetes and Hyperglycemia Elizabeth Barrett-Connor, MD; Elsa-Grace V. Giardina, MD; Anselm K. Gitt, MD; Uwe Gudat, MD; Helmut O. Steinberg, MD; Diethelm Tschoepe, MD Arch Intern Med. 2004;164:934-942.
to research bypass therapies interventional PCI drugs cardiologists medicine artery Dx hyperglycemia cardiology atherosclerosis CABG cardiovascular studies disease glycemic trials glucose procedures syndrome surgery coronary diagnosis Rx plaque Tx occlusion by avivagabriel on Jul 15, 2007, 9:47 PMSurgery does not deal with the basic molecular foundation of disease. It is a mechanical approach to a biologic problem. For those of us who are considered...Surgery does not deal with the basic molecular foundation of disease. It is a mechanical approach to a biologic problem. For those of us who are considered experts in the areas of coronary disease, what an embarrassment to admit that coronary artery disea
to CABG studies artery research trials medicine atherosclerosis disease therapies drugs cure surgery systemic occlusion symptomatic epidemiology cardiologists syndrome coronary plaque cardiology procedures cardiovascular interventional palliative bypass PCI by avivagabriel on Jul 15, 2007, 9:21 PMThe morbidity, mortality, expense and transient benefits of a high technology approach toward the coronary disease epidemic, has failed. It is time to real...The morbidity, mortality, expense and transient benefits of a high technology approach toward the coronary disease epidemic, has failed. It is time to realize that the answer to a faulty lifestyle epidemic is not drugs and technology – it is lifestyle.
to cardiovascular occlusion diagnosis surgery palliative plaque PCI therapies coronary research syndrome atherosclerosis trials cardiology artery procedures symptomatic disease cure bypass interventional studies drugs CABG systemic cardiologists medicine by avivagabriel on Jul 15, 2007, 9:19 PMModern cardiology has given up on curing heart disease. Its aggressive interventions-- coronary artery bypass graft, atherectomy, angioplasty, and stenting...Modern cardiology has given up on curing heart disease. Its aggressive interventions-- coronary artery bypass graft, atherectomy, angioplasty, and stenting--do not reduce the frequency of new heart attacks or prolong survival except in small subsets of pa
to trials artery studies Tx syndrome drugs diagnosis assessments imaging cardiology cardiologists plaque therapies PCI surgery coronary radiography Rx interventional procedures occlusion bypass research disease Dx CABG atherosclerosis medicine cardiovascular by avivagabriel on Jul 15, 2007, 9:13 PMAn unreasonable gap exists between medical enthusiasm devoted to acute interventions and meager efforts devoted to secondary prevention. Rene C. Favaloro, ...An unreasonable gap exists between medical enthusiasm devoted to acute interventions and meager efforts devoted to secondary prevention. Rene C. Favaloro, MD, Pioneer of Coronary Artery Bypass Graft Surgery
to prevention trials cardiology artery cardiologists research coronary systemic atherosclerosis drugs bypass occlusion plaque interventional holistic cardiovascular studies procedures symptomatic preventive medicine CABG disease PCI syndrome surgery by avivagabriel on Jul 15, 2007, 8:41 PMelective PTCA of totally occluded coronary arteries is feasible but the primary success rate is lower (57%) than that associated with conventional lesions....elective PTCA of totally occluded coronary arteries is feasible but the primary success rate is lower (57%) than that associated with conventional lesions. The long-term clinical results following successful angioplasty are satisfactory (64%), but the inc
to CTO CABG drugs PCI trials artery surgery percutaneous total chr cardiology plaque studies medicine atherosclerosis coronary syndrome cardiologists TCO occlusion intervention interventional occlusions procedures research bypass disease cardiovascular by avivagabriel on Jul 15, 2007, 8:35 PMOur patient exemplified the challenges involved in a CTO, which included the length of the lesion, the lack of a proximal nipple, the presence of a side br...Our patient exemplified the challenges involved in a CTO, which included the length of the lesion, the lack of a proximal nipple, the presence of a side branch at the occlusion point, poor visualization of the distal vessel despite contralateral injection
to trials cardiologists occlusion research procedures coronary disease radiography syndrome cardiovascular studies bypass interventional CABG atherosclerosis assessments surgery diagnosis PCI cardiology artery Dx medicine imaging plaque Rx Tx drugs therapies by avivagabriel on Jul 15, 2007, 8:27 PM- to MI coronary function cardiology arteries atherosclerosis valves structure atheroma elasticicity artery disease cardiovascular medicine rhythm occlusion media endothelium syndrome infarction lumen plaque angina embolism adventititia myocardial intima by avivagabriel on Jul 15, 2007, 8:23 PM
- to syndrome artery disease EDTA occlusion cardiovascular nutraceuticals total medicine CTO chelation cardiology atherosclerosis plaque occluded coronary occlusions by avivagabriel on Jul 15, 2007, 7:15 PM
- to delayed drug-eluting wounds stenting vascular coronary injury late artery healing syndrome medicine cardiovascular atherosclerosis occlusion restenosis DES plaque genous stents disease cardiology by avivagabriel on Jul 15, 2007, 7:09 PM
Drug-eluting stents (DES) have gained widespread adoption being implanted in over 6 million patients worldwide demonstrating significant improvements in cl...Drug-eluting stents (DES) have gained widespread adoption being implanted in over 6 million patients worldwide demonstrating significant improvements in clinical efficacy combined with comparable safety to bare metal stents.
to coronary atherosclerosis ACC COURAGE antiplatelets cardiovascular medicine stents boston_scientific syndrome KOLs SCAI disease stone DES paclitaxel plaque drug-eluting stenting artery leon cardiology occlusion taxus baim by avivagabriel on Jul 15, 2007, 7:08 PM- to plaque nutrition omega-3 DHA coronary EFAs EPA omega-6 artery syndrome oils cardiology micronutrients dietary linus disease omega3 atherosclerosis diet institute medicine EFA clinical supplements clinical_nutrition cardiovascular fish nuts pauling fattyacids fishoils occlusion by avivagabriel on Jul 15, 2007, 6:25 PM
- to occlusion cardiology nutrition disease fish syndrome cardiovascular dietary fatty-acids fishoils cliinical_nutrition clinical omega-3 artery n3 atherosclerosis diet plaque omega3 oils medicine coronary fattyacids by avivagabriel on Jul 15, 2007, 6:24 PM
- to fatty-acids supplements fattyacids coronary fish zone disease atherosclerosis brain oils dr_sears n3 nutraceuticals artery docosahexaenoic clinical cardiovascular syndrome omega-3 fishoils diet omega3 plaque cardiology DHA nutrition occlusion medicine by avivagabriel on Jul 15, 2007, 6:22 PM
An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus...An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
to restenosis stenting lumen xience cardiovascular artery stents medicine disease taxus stone drug-eluting atherosclerosis clinical trials cardiology SPIRIT-III late clinical_trials occlusion everolimus NYC late-stage coronary paclitaxel plaque loss syndrome by avivagabriel on Jul 15, 2007, 6:20 PM- to cardiology drugs syndrome occlusion stents disease cardiologists trials cardiovascular interventional drug-eluting clinical atherosclerosis bare-metal coronary medications COURAGE plaque artery medicine systemic symptomatic stenting clinical_trials by avivagabriel on Jul 15, 2007, 6:14 PM
::
avivagabriel ::
